Comparison of ketamine-dexmedetomidine versus ketamine-propofol combination for sedation during short duration urological procedure.

Comparison of ketamine-dexmedetomidine versus ketamine-propofol combination for sedation during short duration urological procedure: A Prospective -Randomised study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/12/022301

Enrollment

Registered

2019-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system

Interventions

Intervention1: Ketamine- Dexmedetomidine with Ketamine- Propofol for sedation: Group KD: Receive inj Dexmedetomidine 1 mcg/ mg over 10 mins intravenous followed by inj. Ketamine 1mg/kg initial dose

Eligibility

Inclusion criteria

Inclusion criteria: -ASA 1 & 2 -Short duration endoscopic Urological procedure (30mins); Urethral balloon dilatation, Urethral calibration, VIU, DJ Stenting or change, Cystoscopy, Cystoscopy-biopsy, OTIS, PCN & etc

Exclusion criteria

Exclusion criteria: -Patients with upper respiratory tract infections, psychosis, increased intracranial tension, neurologic diseases & glaucoma -History of hypersensitivity to any of the study drugs were excluded from the study. -Patients refuse for giving consent.

Design outcomes

Primary

Measure	Time frame
Safety and efficacy of Ketomine-Dexmedetomide vs Ketamine - Propofol for sedation during short duration urological procedure.Timepoint: Till patient is ready to discharge	—

Secondary

Measure	Time frame
Emergent delirium, post-procedure pain score and recovery time.Timepoint: Till Patient is ready for discharge	—

Countries

India

Contacts

Public ContactDINESHBHAI PRAJAPATI

MULJIBHAI PATEL UROLOGICAL HOSPITAL

dr_djp2011@hotmail.com9879399866

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026